Inventor · disambiguated record
James Lamond Ellis
Also filed as: ELLIS JAMES · ELLIS JAMES L · ELLIS JAMES LAMOND
25 granted patents·16 pending applications·138 citations·filing 2000–2024
96Inventor score
Top patents by PatentIndex Score
41 records- 0198US10968179B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Apr 6, 2021·9 cites·18 claims
- 0298US10933055B1Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·8 cites·22 claims
- 0398US10934263B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·9 cites·20 claims
- 0498US10925865B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Feb 23, 2021·9 cites·18 claims
- 0598US10927096B2Ester substituted ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Feb 23, 2021·8 cites·18 claims
- 0698US10842798B1Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Nov 24, 2020·11 cites·13 claims
- 0797US11603355B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Mar 14, 2023·5 cites·19 claims
- 0897US11512058B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Nov 29, 2022·5 cites·20 claims
- 0997US11377422B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Jul 5, 2022·5 cites·13 claims
- 1097US11332446B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2021·Granted May 17, 2022·6 cites·21 claims
- 1197US10786485B1Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2019·Granted Sep 29, 2020·10 cites·27 claims
- 1296US11696912B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Jul 11, 2023·3 cites·21 claims
- 1396US11643404B2Ester substituted ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted May 9, 2023·5 cites·20 claims
- 1495US10828287B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2019·Granted Nov 10, 2020·8 cites·22 claims
- 1595US10780083B1Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2019·Granted Sep 22, 2020·8 cites·28 claims
- 1689US2025263374A1Charged Ion Channel Blockers and Methods for UseNOCION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1789US2025263375A1Charged Ion Channel Blockers and Methods for UseNOCION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1887US11618761B2Phosphonium ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Apr 4, 2023·1 cites·24 claims
- 1986US2025270189A1Ester Substituted Ion Channel Blockers and Methods for UseNOCION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2084US11701370B2Phosphonium ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Granted Jul 18, 2023·1 cites·19 claims
- 2183US2023192613A1Charged Ion Channel Blockers and Methods for UseNOCION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2282US12195428B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2022·Granted Jan 14, 2025·0 cites·24 claims
- 2381US2024116895A1Ester substituted ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2480US12303496B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2023·Granted May 20, 2025·0 cites·22 claims
- 2579US2024277727A1Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2677US2025263386A1Charged Ion Channel Blockers and Methods for UseNOCION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2776US6451801B1Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2000·Granted Sep 17, 2002·9 cites·22 claims
- 2875US2024076305A1Phosphonium Ion Channel Blockers and Methods for UseNOCION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2974US2023107360A1Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3072US6894059B1Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2000·Granted May 17, 2005·7 cites·11 claims
- 3172US6828328B1Analgesic combination of muscarinic agonistsUCB SA·Filed 2002·Granted Dec 7, 2004·8 cites·5 claims
- 3268US6797713B2Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2002·Granted Sep 28, 2004·3 cites·2 claims
- 3367US2025120960A1Compositions and Methods for Treatment of Inflammatory Bowel DiseaseNOCION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3467US2021128578A1Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3566US12162851B2Charged ion channel blockers and methods for useNOCION THERAPEUTICS INC·Filed 2021·Granted Dec 10, 2024·0 cites·26 claims
- 3652US2004048875A1Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2003·Application pending·0 cites
- 3749US2009018091A1Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of UseNITROMED INC·Filed 2006·Application pending·0 cites
- 3846US2009042819A1Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of useNITROMED INC·Filed 2006·Application pending·0 cites
- 3943US10072011B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Sep 11, 2018·0 cites·14 claims
- 4042US2009131342A1Nitrosated and/or nitrosylated compounds, compositions and methods of useNITROMED INC·Filed 2005·Application pending·0 cites
- 4136US2008153917A1Sigma Receptor LigandsUCB PHARMA SA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Lamond Ellis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →